Yunzhou Pu

423 total citations · 1 hit paper
9 papers, 291 citations indexed

About

Yunzhou Pu is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Yunzhou Pu has authored 9 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in Yunzhou Pu's work include Extracellular vesicles in disease (4 papers), Immune cells in cancer (3 papers) and Circular RNAs in diseases (2 papers). Yunzhou Pu is often cited by papers focused on Extracellular vesicles in disease (4 papers), Immune cells in cancer (3 papers) and Circular RNAs in diseases (2 papers). Yunzhou Pu collaborates with scholars based in China. Yunzhou Pu's co-authors include Qing Ji, Haoze Li, Huirong Zhu, Xinnan Wu, Ling Li, Qing Song, Yang Liu, Lihong Zhou, Guanghao Zhu and Jian Sun and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Molecular Cancer.

In The Last Decade

Yunzhou Pu

9 papers receiving 289 citations

Hit Papers

Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosu... 2022 2026 2023 2024 2022 50 100 150

Peers

Yunzhou Pu
Comparison fields: 5 of 49
  • Molecular Biology 129
  • Immunology 115
  • Oncology 104
  • Cancer Research 65
  • Pulmonary and Respiratory Medicine 34
Replace Marie Ancion with:
Marie Ancion Belgium
Binhua Wu China
Charlotte Pilard Belgium
Elena Kazakova Russia
Juchuanli Tu China
Shunfeng Hu China
Ritu Arora United States
David L. Elion United States
Shiyong Neo Singapore
Xiangbo Meng China
Marie Ancion Belgium View profile →
Citations per field, relative to Yunzhou Pu
Yunzhou Pu · 1×
Citations per year, relative to Yunzhou Pu
Yunzhou Pu · 1×

Countries citing papers authored by Yunzhou Pu

Since Specialization
Citations

This map shows the geographic impact of Yunzhou Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunzhou Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunzhou Pu more than expected).

Fields of papers citing papers by Yunzhou Pu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunzhou Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunzhou Pu. The network helps show where Yunzhou Pu may publish in the future.

Co-authorship network of co-authors of Yunzhou Pu

This figure shows the co-authorship network connecting the top 25 collaborators of Yunzhou Pu. A scholar is included among the top collaborators of Yunzhou Pu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunzhou Pu. Yunzhou Pu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
# Work Indexed citations
1 4
2 27
3 19
4 11
5 11
6 2
7 5
8 30
9
Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression breakdown →
182

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026